Home > Press > Dr. Andrey Zarur Joins Kodiak Venture Partners
- Life sciences and high technology expert will focus on investing at the intersection of healthcare and IT -
Dr. Andrey Zarur Joins Kodiak Venture Partners
WALTHAM, MA | Posted on February 26th, 2007
Dr. Andrey Zarur has joined Kodiak Venture Partners, a seed and early stage venture capital firm, as General Partner. Zarur will source deals and support Kodiak portfolio companies within the intersection of the healthcare and high technology markets.
Recent years have seen a significant market emerge as a result of the convergence of life sciences and information technology disciplines. Kodiak recognizes this fast-growing market as the evolution of traditional investment areas such as IT and IT-related software and services as they begin to propagate into the healthcare and medical devices markets. The concentration of world class academic centers and teaching hospitals, coupled with a fertile ground for new ventures in these segments, make the Greater Boston area especially attractive for investing in companies focusing on convergence of healthcare and IT. Kodiak has made two investments in this area, ALIS (acquired by Carl Zeiss SMT in July 2006) and Cambridge Devices.
"I am thrilled to join Kodiak and spearhead entry into this exciting market," said Zarur. "The firm's dedication to early stage investing, strong entrepreneurial focus and dynamic team position us for success."
Andrey Zarur, Ph.D., has over 15 years of operating and investing experience. He joins Kodiak from BioProcessors, where he was founder and CEO. Prior to BioProcessors, Zarur served as an executive, investor or board member of over ten startups in areas including bioinformatics, genomics, medical devices, nanotechnology-derived materials and energy systems. He currently serves on the scientific advisory boards of Anecova and StemLife, and serves on the boards of directors of BioProcessors and Cambridge Devices (a Kodiak portfolio company). Zarur is also a director of Infantia, a foundation that provides education and board to underprivileged children in developing countries.
Zarur has earned several prestigious academic and management awards, authored over 20 articles in peer-reviewed journals, counts over 100 issued and pending patents to his name, and lectures at the Sloan School of Management at the Massachusetts Institute of Technology (MIT). He earned a B.Sc. in chemical engineering from the National University of Mexico, and a M.Sc.B. and a Ph.D. in chemical engineering from MIT.
"We have seen the evolution of the IT market over the past few funds, and decided to evolve with it by adding these converging disciplines into our investing focus," said Lou Volpe, Managing General Partner, Kodiak Venture Partners. "We have known and interacted with Andrey for several years and view him as the perfect complement to the Kodiak team—he brings the operational and technological expertise, and hands-on approach of all our partners into investments in these areas."
About Kodiak Venture Partners
Kodiak Venture Partners is a Waltham, Mass.-based venture capital firm focused on seed and early stage investments in emerging communications/wireless, semiconductor/equipment, software/services and Internet/new media companies. With a focus in the eastern regions of the U.S. and Canada, Kodiak establishes relationships with entrepreneurs seeking market success. Kodiak’s investment partners are successful high-technology business entrepreneurs who take a hands-on approach to building market leaders.
For more information, please click here
Vicki Sakakeeny, 011 506 342 3877
Kodiak Venture Partners
Liz Neal, 781-684-0222
Copyright © Business Wire
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Malaysian Nanotechnology Company Nanopac Innovation Ltd. lists on the NSX January 19th, 2015
Aspen Aerogels, Inc. to Present at the Needham Growth Conference January 8th, 2015
Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin™ Platform for Cancer Therapeutics: Company’s Technology and Expertise in Cancer R&D Evolve to Create New Class of Miniaturized Biologic Drug Conjugates (mBDCs) Encapsulated in Nanoparticles January 8th, 2015
Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 2, 2015 January 7th, 2015
Iranian Scientists Use MOFs to Eliminate Dye Pollutants January 29th, 2015
Made-in-Singapore rapid test kit detects dengue antibodies from saliva: IBN's MedTech innovation simplifies diagnosis of infectious diseases January 29th, 2015
'Bulletproof' battery: Kevlar membrane for safer, thinner lithium rechargeables January 28th, 2015
Spider electro-combs its sticky nano-filaments January 28th, 2015
Rice's Naomi Halas to direct Smalley Institute: Optics pioneer will lead Rice's multidisciplinary science institute January 15th, 2015
SUNY Board Appoints Dr. Alain Kaloyeros as Founding President of SUNY Polytechnic Institute January 13th, 2015
Blend Therapeutics Appoints Distinguished Physician Scientist, Dennis Ausiello, MD, to Board of Directors January 8th, 2015
QD Vision Receives New Funding Round to Meet Growing Demand for Quantum Dot Technology: Industry Veteran Steve Ward Named Executive Chairman January 5th, 2015